BLANDINI, FABIO
BLANDINI, FABIO
DIPARTIMENTO DI SCIENZE DEL SISTEMA NERVOSO E DEL COMPORTAMENTO
A 2A receptor antagonism and dyskinesia in parkinson's disease
2012-01-01 Morelli, M.; Blandini, F.; Simola, N.; Hauser, R. A.
A further update on the role of excitotoxicity in the pathogenesis of Parkinson’s disease
2014-01-01 Ambrosi, G.; Cerri, S.; Blandini, F.
A new 5-HT2 antagonist (ritanserin) in the treatment of chronic headache with depression. A double-blind study vs amitriptyline.
1990-01-01 Nappi, Giuseppe; Sandrini, Giorgio; Granella, Franco; L., Ruiz; Cerutti, Giuditta; Facchinetti, Fabio; Blandini, Fabio; Manzoni, GIAN CAMILLO
A reliable indirect cell-labelling protocol for optical imaging allows ex vivo visualisation of mesenchymal stem cells after transplantation
2013-01-01 Diana, Valentina; Libani, Ilaria Vittoria; Armentero, Marie-Therese; Blandini, Fabio; Lucignani, Giovanni; Silani, Vincenzo; Cova, Lidia; Ottobrini, Luisa
Activation of brain metabolism and fos during limbic seizures: The role of Locus Coeruleus
2008-01-01 Giorgi, F. S.; Blandini, F.; Cantafora, E.; Biagioni, F.; Armentero, M. -T.; Pasquali, L.; Orzi, F.; Murri, L.; Paparelli, A.; Fornai, F.
Activation of the CREB/c-Fos Pathway during Long-Term Synaptic Plasticity in the Cerebellum Granular Layer
2017-01-01 Gandolfi, Daniela; Cerri, Silvia; Mapelli, Jonathan; Polimeni, Mariarosa; Tritto, Simona; Fuzzati Armentero, Marie Therese; Bigiani, Albertino; Blandini, Fabio; Mapelli, Lisa; D'Angelo, EGIDIO UGO
Activation of the DNA damage response in vivo in synucleinopathy models of Parkinson’s disease
2018-01-01 Milanese, C.; Cerri, S.; Ulusoy, A.; Gornati, S. V.; Plat, A.; Gabriels, S.; Blandini, F.; Di Monte, D. A.; Hoeijmakers, J. H.; Mastroberardino, P. G.
Activation of the DNA damage response in vivo in synucleinopathy models of Parkinson’s disease
2018-01-01 Milanese, C.; Cerri, S.; Ulusoy, A.; Gornati, S. V.; Plat, A.; Gabriels, S.; Blandini, F.; Di Monte, D. A.; Hoeijmakers, J. H.; Mastroberardino, P. G.
Acute Reduction of Anandamide-Hydrolase (FAAH) Activity is Coupled With a Reduction of Nociceptive Pathways Facilitation in Medication-Overuse Headache Subjects After Withdrawal Treatment.
2012-01-01 Perrotta, Armando; Arce Leal, N; Tassorelli, Cristina; Gasperi, Valentina; Sances, G; Blandini, Fabio; Serrao, M; Bolla, Monica; Pierelli, Francesco; Nappi, Giuseppe; Maccarrone, M; Sandrini, Giorgio
Adenosine receptors and L-DOPA-induced dyskinesia in Parkinson's disease: Potential targets for a new therapeutic approach
2003-01-01 Blandini, F.
Adhesion molecules as potential targets for neuroprotection in a rodent model of Parkinson's disease
2011-01-01 Armentero, M. -T.; Levandis, G.; Bazzini, E.; Cerri, S.; Ghezzi, C.; Blandini, F.
Age-related changes of protein SUMOylation balance in the AβPP Tg2576 mouse model of Alzheimer's disease
2014-01-01 Nistico, R.; Ferraina, C.; Marconi, V.; Blandini, F.; Negri, L.; Egebjerg, J.; Feligioni, M.
Aging and dementia: markers of the hypothalamus-pituitary-adrenal axis and sympathetic activities in biological fluids
1990-01-01 Nappi, G.; Martignoni, E.; Costa, Alfredo; Petraglia, F.; Blandini, F.; Bono, G.; Genazzani, A. R.
Alteration of colonic excitatory tachykininergic motility and enteric inflammation following dopaminergic nigrostriatal neurodegeneration
2016-01-01 Pellegrini, C.; Fornai, M.; Colucci, R.; Tirotta, E.; Blandini, F.; Levandis, G.; Cerri, S.; Segnani, C.; Ippolito, C.; Bernardini, N.; Cseri, K.; Blandizzi, C.; Hasko, G.; Antonioli, L.
Alterazioni neurochimiche del sistema nervoso enterico (SNE) in un modello sperimentale di Parkinson
2011-01-01 Fragassi, G.; Colucci, M.; Cervio, M.; Levandis, G.; Vicini, Riccardo; Balestra, Barbara; Tassorelli, Cristina; Pastoris, Ornella; Blandini, F.; Stanghellini, V.; Barbara, G.; Corinaldesi, R.; Tonini, Marcello; De Giorgio, R.
Ambroxol-induced rescue of defective glucocerebrosidase is associated with increased LIMP-2 and saposin C levels in GBA1 mutant Parkinson's disease cells
2015-01-01 Ambrosi, G.; Ghezzi, C.; Zangaglia, R.; Levandis, G.; Pacchetti, C.; Blandini, F.
An update on the potential role of excitotoxicity in the pathogenesis of Parkinson's disease
2010-01-01 Blandini, Fabio
An update on the use of non-ergot dopamine agonists for the treatment of Parkinson’s disease
2020-01-01 Cerri, S.; Blandini, F.
Animal models of Parkinson's disease
2012-01-01 Blandini, F.; Armentero, M. -T.
Assay of [3H] dihydrorotenone binding to complex I in intact human platelets
1995-01-01 Blandini, F.; Greenamyre, J. T.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A 2A receptor antagonism and dyskinesia in parkinson's disease | 1-gen-2012 | Morelli, M.; Blandini, F.; Simola, N.; Hauser, R. A. | |
| A further update on the role of excitotoxicity in the pathogenesis of Parkinson’s disease | 1-gen-2014 | Ambrosi, G.; Cerri, S.; Blandini, F. | |
| A new 5-HT2 antagonist (ritanserin) in the treatment of chronic headache with depression. A double-blind study vs amitriptyline. | 1-gen-1990 | Nappi, Giuseppe; Sandrini, Giorgio; Granella, Franco; L., Ruiz; Cerutti, Giuditta; Facchinetti, Fabio; Blandini, Fabio; Manzoni, GIAN CAMILLO | |
| A reliable indirect cell-labelling protocol for optical imaging allows ex vivo visualisation of mesenchymal stem cells after transplantation | 1-gen-2013 | Diana, Valentina; Libani, Ilaria Vittoria; Armentero, Marie-Therese; Blandini, Fabio; Lucignani, Giovanni; Silani, Vincenzo; Cova, Lidia; Ottobrini, Luisa | |
| Activation of brain metabolism and fos during limbic seizures: The role of Locus Coeruleus | 1-gen-2008 | Giorgi, F. S.; Blandini, F.; Cantafora, E.; Biagioni, F.; Armentero, M. -T.; Pasquali, L.; Orzi, F.; Murri, L.; Paparelli, A.; Fornai, F. | |
| Activation of the CREB/c-Fos Pathway during Long-Term Synaptic Plasticity in the Cerebellum Granular Layer | 1-gen-2017 | Gandolfi, Daniela; Cerri, Silvia; Mapelli, Jonathan; Polimeni, Mariarosa; Tritto, Simona; Fuzzati Armentero, Marie Therese; Bigiani, Albertino; Blandini, Fabio; Mapelli, Lisa; D'Angelo, EGIDIO UGO | |
| Activation of the DNA damage response in vivo in synucleinopathy models of Parkinson’s disease | 1-gen-2018 | Milanese, C.; Cerri, S.; Ulusoy, A.; Gornati, S. V.; Plat, A.; Gabriels, S.; Blandini, F.; Di Monte, D. A.; Hoeijmakers, J. H.; Mastroberardino, P. G. | |
| Activation of the DNA damage response in vivo in synucleinopathy models of Parkinson’s disease | 1-gen-2018 | Milanese, C.; Cerri, S.; Ulusoy, A.; Gornati, S. V.; Plat, A.; Gabriels, S.; Blandini, F.; Di Monte, D. A.; Hoeijmakers, J. H.; Mastroberardino, P. G. | |
| Acute Reduction of Anandamide-Hydrolase (FAAH) Activity is Coupled With a Reduction of Nociceptive Pathways Facilitation in Medication-Overuse Headache Subjects After Withdrawal Treatment. | 1-gen-2012 | Perrotta, Armando; Arce Leal, N; Tassorelli, Cristina; Gasperi, Valentina; Sances, G; Blandini, Fabio; Serrao, M; Bolla, Monica; Pierelli, Francesco; Nappi, Giuseppe; Maccarrone, M; Sandrini, Giorgio | |
| Adenosine receptors and L-DOPA-induced dyskinesia in Parkinson's disease: Potential targets for a new therapeutic approach | 1-gen-2003 | Blandini, F. | |
| Adhesion molecules as potential targets for neuroprotection in a rodent model of Parkinson's disease | 1-gen-2011 | Armentero, M. -T.; Levandis, G.; Bazzini, E.; Cerri, S.; Ghezzi, C.; Blandini, F. | |
| Age-related changes of protein SUMOylation balance in the AβPP Tg2576 mouse model of Alzheimer's disease | 1-gen-2014 | Nistico, R.; Ferraina, C.; Marconi, V.; Blandini, F.; Negri, L.; Egebjerg, J.; Feligioni, M. | |
| Aging and dementia: markers of the hypothalamus-pituitary-adrenal axis and sympathetic activities in biological fluids | 1-gen-1990 | Nappi, G.; Martignoni, E.; Costa, Alfredo; Petraglia, F.; Blandini, F.; Bono, G.; Genazzani, A. R. | |
| Alteration of colonic excitatory tachykininergic motility and enteric inflammation following dopaminergic nigrostriatal neurodegeneration | 1-gen-2016 | Pellegrini, C.; Fornai, M.; Colucci, R.; Tirotta, E.; Blandini, F.; Levandis, G.; Cerri, S.; Segnani, C.; Ippolito, C.; Bernardini, N.; Cseri, K.; Blandizzi, C.; Hasko, G.; Antonioli, L. | |
| Alterazioni neurochimiche del sistema nervoso enterico (SNE) in un modello sperimentale di Parkinson | 1-gen-2011 | Fragassi, G.; Colucci, M.; Cervio, M.; Levandis, G.; Vicini, Riccardo; Balestra, Barbara; Tassorelli, Cristina; Pastoris, Ornella; Blandini, F.; Stanghellini, V.; Barbara, G.; Corinaldesi, R.; Tonini, Marcello; De Giorgio, R. | |
| Ambroxol-induced rescue of defective glucocerebrosidase is associated with increased LIMP-2 and saposin C levels in GBA1 mutant Parkinson's disease cells | 1-gen-2015 | Ambrosi, G.; Ghezzi, C.; Zangaglia, R.; Levandis, G.; Pacchetti, C.; Blandini, F. | |
| An update on the potential role of excitotoxicity in the pathogenesis of Parkinson's disease | 1-gen-2010 | Blandini, Fabio | |
| An update on the use of non-ergot dopamine agonists for the treatment of Parkinson’s disease | 1-gen-2020 | Cerri, S.; Blandini, F. | |
| Animal models of Parkinson's disease | 1-gen-2012 | Blandini, F.; Armentero, M. -T. | |
| Assay of [3H] dihydrorotenone binding to complex I in intact human platelets | 1-gen-1995 | Blandini, F.; Greenamyre, J. T. |